Evolution of implantable and insertable drug delivery systems

Journal of Controlled Release

Volumn 181, Issue 1, 2014, Pages 1-10

  Kleiner, Lothar W ^a   Wright, Jeremy C ^b   Wang, Yunbing ^c  

^a Polteco Company   (United States)

^b DURECT Corporation   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Bioresorbable vascular scaffold; Drug implant; Drug eluting stent; Implantable drug delivery system; Implantable pump; Insertable drug delivery system

Indexed keywords

DISEASE CONTROL; DRUG DELIVERY; SCAFFOLDS;

DRUG DELIVERY SYSTEM; DRUG-ELUTING STENTS; IMPLANTABLE DRUG DELIVERY SYSTEMS; IMPLANTABLE PUMPS; VASCULAR SCAFFOLDS;

DISEASES;

BIRTH CONTROL; CANCER THERAPY; DRUG DELIVERY SYSTEM; EYE DISEASE; IMPLANTABLE DRUG DELIVERY SYSTEM; IMPLANTABLE PUMP; INFUSION PUMP; OSMOTIC PUMP; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; CHEMISTRY; DEVICES; DRUG IMPLANT; EQUIPMENT DESIGN; HUMAN; PROCEDURES;

BIOMATERIAL; DRUG CARRIER; DRUG IMPLANT;

BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; EQUIPMENT DESIGN; HUMANS; INFUSION PUMPS, IMPLANTABLE;

EID: 84896120465     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.02.006     Document Type: Review

References (89)

1. J. Folkman, and D.M. Long The use of silicone rubber as a carrier for prolonged drug therapy J. Surg. Res. 4 1964 139 142
2. R. Langer, and J. Folkman Polymers for the sustained release of proteins and other macromolecules Nature 263 1976 797 800
3. A.S. Hoffman The origins and evolution of "controlled" drug delivery systems J. Control. Release 132 2008 153 163
4. E.M. Del Valle, M.A. Galan, and R.G. Carbonell Drug delivery technologies: the way forward in the new decade Ind. Eng. Chem. Res. 48 2009 2475 2486
5. H. Jaffe, P.A. Giang, D.K. Hayes, J.A. Miller, and B.H. Stroud Implantable systems for delivery of insect growth regulators to livestock II Control. Release Pestic. Pharm. 7 1981 303 310
6. R.L. Dunn, D.H. Lewis, and L.R. Beck Fibrous polymers for the delivery of contraceptive steroids to the female reproductive tract Control. Release Pestic. Pharm. 7 1981 125 146
7. C.L. McCormick, K.W. Anderson, J.A. Pelezo, and D.K. Lichatowich Controlled release of metribuzin, 2,4-D, and model aromatic amines from polysaccharides and poly(vinyl alcohol) Control. Release Pestic. Pharm. 7 1981 147 158
8. R.G. Wheeler, and P.G. Friel Release of drugs from IUDs using an ethylene vinyl acetate matrix Control. Release Pestic. Pharm. 7 1981 111 124
9. D.S. Hsieh, and R. Langer Experimental approaches for achieving both zero-order and modulated controlled release from polymer matrix systems Control. Release Pestic. Pharm. 7 1981 5 15
10. B. Vernon, and M. Wegner Controlled release Encycl. Biomater. Biomed. Eng. 1 2004 384 391
11. A.k. Dash, and G.C. Cudworth Therapeutic applications of implantable drug delivery systems J. Pharmacol. Toxicol. Methods 40 1998 1 12
12. D.H. Lewis Controlled release of bioactive agents from lactide/glycolide polymers Drugs Pharm. Sci. 45 1990 1 41
13. M. Pizzi, O. De Martiis, and V. Grasso Fabrication of self-assembled micro reservoirs for controlled drug release Biomed. Microdevices 6 2004 155 158 (Pubitemid 38801857)
14. S. Lyu, and D. Untereker Degradability of polymers for implantable biomedical devices Int. J. Mol. Sci. 10 2009 4033 4065
15. S. Alam, J.B. Baldwin, K.A. Tombros, B. Rinehart, W.C. Shields, and A.M. Swann The single-rod contraceptive implant Clinicalproceedings® from Association of Reproductive Health Professionals 2008 7 9
16. N. Kukreja, Y. Onuma, and P.W. Serruys Future directions of drug-eluting stents J. Interv. Cardiol. 22 2009 96 105
17. R. Virmani, A.K. Finn, and F.D. Kolodgie A review of current devices and a look at new technology: drug eluting stents Expert Rev. Med. Devices 6 2009 33 42
18. G. Mani, M.D. Feldman, D. Patel, and C.M. Agrawal Coronary stents: a materials perspective Biomaterials 28 2007 1689 1710 (Pubitemid 46080469)
19. Vitrasert Package Insert http://www.bausch.com/en-US/package-insert/ surgical/vitrasert-pkg-insert.pdf (date accessed 14/11/09)
20. S.S. Lee, P. Yuan, and M.R. Robinson Ocular implants for drug delivery G.E. Wnek, G.L. Bowlin, Encyclopedia of Biomaterials and Biomedical Engineering Second edition Informa Healthcare, USA vol. 3 2008 1981 1995
21. J.L. Bourges, C. Bloquel, A. Thomas, F. Froussart, A. Bochot, F. Azan, R. Gurny, D. BenEzra, and F. Behar-Cohen Intraocular implants for extended drug delivery: therapeutic applications Adv. Drug Deliv. Rev. 58 2006 1182 1202 (Pubitemid 44794429)
22. E. Edelman Invited presentation: polymer bioabsorption fundamentals and differences among DES systems Transcatheter Cardiovascular Therapeutics 21st Annual Conference, September 21-25, 2009, San Francisco, CA 2009
23. J.A. Ormiston, and P.W. Serruys Bioabsorbable coronary stents Circ. Cardiovasc. Interv. 2 2009 255 260
24. D. Chan-Seng, T. Ranganathan, X. Zhang, Y. Tang, Q. Lin, L. Kleiner, and T. Emrick Aliphatic polyester terpolymers for stent coating and drug elution: effect of polymer composition on drug solubility and release Drug Deliv. 16 2009 304 311
25. G. Acharya, and K. Park Mechanisms of controlled drug release from drug-eluting stents Adv. Drug Deliv. Rev. 58 2006 387 401 (Pubitemid 43816741)
26. A. Perry, S. Arie, and E. Robert Cancer therapy-associated CNS neuropathology: an update and review of the literature Acta Neuropathol. 111 2006 197 212
27. Eisai Co., Ltd. Gliadel® Wafer (Polifeprosan 20 with Carmustine Implant) Rx Only http://www.eisai.com/pdf-files/gliadel-pi.pdf (Accessed September 05, 2013)
28. Zoladex® 3.6 mg Implant Information http://www1.astrazeneca-us.com/ pi/zoladex3-6.pdf (Date accessed September 05, 2013)
29. Zoladex® 10.8 mg Implant Information http://www1.astrazeneca-us.com/ pi/zoladex10-8.pdf (Date accessed September 05, 2013)
30. V.B. Kotwal, M. Saifee, N. Inamdar, and K. Bhise Biodegradable polymers: which, when and why Indian J. Pharm. Sci. 69 2007 616 625
31. D.W. Isenbarger, and J.R. Resar Drug-eluting versus third-generation bare metal stents: the US strategy Int. J. Cardiovasc. Interv. 7 2005 171 175 (Pubitemid 43030912)
32. Y. Onuma, and P.W. Serruys Bioresorbable scaffold - the advent of a new era in percutaneous coronary and peripheral revascularization Circulation 123 2011 779 797
33. M. Haude, and R. Erbel et al. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial Lancet 381 2013 836 844
34. Y. Wang, L. Kleiner, Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct, US patent number 8,372,332, issued on February 12, 2013.
35. Y. Wang, Bioabsorbable stent with layers having different degradation rates, US patent number 8,057,876, issued on November 15, 2011.
36. Y. Wang, D. Gale, B. Huang, Implantable medical devices fabricated from polymer blends with star-block copolymers, US patent number 8,262,723, issued on September 11, 2012.
37. Y. Wang, Implantable medical devices fabricated from polyurethanes with biodegradable hard and soft blocks and blends thereof, US patent number 8,501,290, issued on August 6, 2013.
38. Y. Wang, D. Castrol, S. Pacetti, Methods to improve adhesion of polymer coatings over stents, US Patent number 7,998,524, issued August 16, 2011.
39. P.W. Serruys, J.A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hebert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
40. J. Oberhauser, S. Hossainy, and R. Rapoza Design principles and performance of bioresorbable polymeric coronary scaffolds EuroIntervention 5 2009 15 22
41. S. Hossany, R. Rapoza, J. Oberhauser, Y. Wang; Bioabsorbable Stent And Treatment That Elicits Time-Varying Host-Material Response, US Patent Application No: 2010/0198,330, Filing date Jul 20, 2009.
42. Abbott Bioresorbable Vascular Scaffold press release on January 8, 2013 http://www.abbott.com/press-release/abbott-initiates-clinical-trial-of-absorb- in-the-united-states.htm
43. Abbott Bioresorbable Vascular Scaffold press release on September 25, 2012 http://www.abbott.com/news-media/press-releases/abbott-announces- international-launch-of-the-absorb-bioresorbable-vascular-scaffold.htm
44. B.D. Gogas, V. Farooq, Y. Onuma, and P.W. Serruys The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology Hellenic J. Cardiol. 53 2012 301 309
45. E. Nikolsky, A.J. Lansky, K. Sudhir, J. Doostzadeh, D.E. Cutlip, R. Piana, X. Su, R. White, C. Simonton, and G. Stone SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease Am. Heart J. 158 2009 520 526
46. Allergan Ozurdex® product http://www.ozurdex.com/HCP/Default.aspx (date accessed February 7, 2013)
47. F. Theeuwes, and S.I. Yum Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations Ann. Biomed. Eng. 4 1976 343 353
48. J.C. Wright, S.T. Leonard, C.L. Stevenson, J.C. Beck, G. Chen, and R. Jao An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer J. Control. Release 75 2001 1 10 (Pubitemid 32635192)
49. J.C. Wright, and J. Culwell Long-term controlled delivery of therapeutic agents by the osmotically driven DUROS® Implant M.J. Rathbone, J. Hadgraft, M.S. Roberts, M.E. Lane, Modified-Release Drug Delivery Technology 2nd edition Informa Healthcare 2 2008 New York 143 149
50. J.C. Wright, R.M. Johnson, and S.I. Yum DUROS® osmotic pharmaceutical systems for parenteral and site-directed therapy Drug Deliv. Technol. 3 2003 3 11
51. B. Yang, C. Rohloff, R. Mercer, K. Horwege, C. Negulescu, and S. Lautenbach Continuous delivery of stabilized proteins and peptides at consistent rates for at least 3 months from the DUROS® device Am Assoc Pharm Sci Annual Meeting 2008 (Weblink: http://www.intarcia.com/documents/ DUROSAAPSPosterNov18-2008.pdf., accessed September 6, 2013)
52. ITCA 650 http://www.intarcia.com/products-technology/type2-diabetes.html (accessed September 21, 2013)
53. Medtronic Diabetes Product Information http://www.medtronicdiabetes.com/ products (accessed February 7, 2013)
54. Medtronic Diabetes Infusion Pump History http://en.wikipedia.org/wiki/ Medtronic-Diabetes (accessed February 7, 2013)
55. Medtronic Paradigm Revel Insulin Pump http://www.medtronicdiabetes.com/ products/paradigmrevelpump (accessed February 7, 2013)
56. A.E. Panteleon, M. Loutseiko, G.M. Steil, and K. Rebrin Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system Diabetes 55 2006 1995 2000 (Pubitemid 44509972)
57. M. Danckwerts, and A. Fassihi Implantable controlled release drug delivery systems: a review Drug Dev. Ind. Pharm. 17 1991 1465 1502
58. E.S. Krames Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines J. Pain Symptom Manage. 11 1996 333 352 (Pubitemid 26157413)
59. Medtronic Synchromed® pump information http://professional.medtronic. com/pt/neuro/idd/prod/synchromed-ii/features-specifications/index.htm#. UiWFjWzn-rc (accessed September 5, 2013)
60. P. Gardner Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities Expert Opin. Drug Deliv. 3 2006 479 487
61. E. Nuxoll, and R. Siegel Bio-MEMS devices for drug delivery IEEE Eng. Med. Biol. Mag. 28 2009 31 39
62. E. Meng, and T. Hoang Micro- and nano-fabricated implantable drug-delivery systems Ther. Deliv. 3 2012 1457 1467
63. J. Santini, M.J. Cima, and R. Langer A controlled release microchip Nature 397 1999 335 338
64. W. Paul, and C.P. Sharma Ceramic drug delivery: a perspective J. Biomater. Appl. 17 2003 253 264
65. A. Aneja, J. Woodall, S. Wingerter, M. Tucci, and H. Benghuzzi Analysis of tobramycin release from beta tricalcium phosphate drug delivery system Biomed. Sci. Instrum. 44 2008 88 93
66. K.C. Souza, J.D. Ardisson, and E.M. Sousa Study of mesoporous silica/magnetite systems in drug controlled release J. Mater. Sci. Mater. Med. 20 2009 507 512
67. H. Wu, T. Wang, J. Sun, W. Wang, and F. Lin A novel biomagnetic nanoparticle based on hydroxyapatite Nanotechnology 18 2007 1 9
68. L. Kleiner, S. Hossainy, I. Astafieva, S. Pacetti, T. Glauser, J. Desnoyer, Microporous ceramic, metallic or glassy coating on medical devices such as stents for controlled release of bioactive agent, US Patent application number US20070259101 A1.
69. K. Heilmann Therapeutic Systems 1978 Goerg Thieme Publishers
70. Bayer HealthCare Pharmaceuticals Inc. Mirena Package Insert http://berlex.bayerhealthcare.com/html/products/pi/Mirena-PI.pdf 2009 (date accessed 14/11/09)
71. G. Benagiano, H. Gabelnick, and M. Farris Contraceptive devices: intravaginal and intrauterine delivery systems Expert Rev. Med. Devices 5 2008 639 654
72. http://www.rxlist.com/nuvaring-drug.htm (accessed September 5, 2013)
73. T. Higuchi Mechanism of sustained-action medication J. Pharm. Sci. 52 1963 1145 1149
74. N. Blanchemain, Y. Karrout, N. Tabary, M. Bria, C. Neut, H.F. Hildebrand, J. Siepmann, and B. Martel Comparative study of vascular prostheses coated with polycyclodextrins for controlled ciprofloxacin release Carbohydr. Polym. 90 2012 1695
75. Y. Rosiaux, S. Muschert, R. Chokshi, B. Leclercq, F. Siepmann, and J. Siepmann Ethanol-resistant polymeric film coatings for controlled drug delivery 169 2013 1 9
76. D.R. Paul, and S.K. McSpadden Diffusional release of a solute from a polymer matrix J. Membr. Sci. 1 1976 33 48
77. F. Theeuwes Elementary osmotic pump J. Pharm. Sci. 64 1975 1987 1991
78. F. Rossi, T. Casalini, E. Raffa, M. Masi, and G. Perale Bioresorbable polymer coated drug eluting stent: a model study Mol. Pharm. 9 2012 1898 1910
79. S. Hossainy, and S. Prabhu A mathematical model for predicting drug release from a biodurable drug-eluting stent coating J. Biomed. Mater. Res. A 87 2008 487 493
80. S. Prabhu, and S. Hossainy Modeling of degradation and drug release from a biodegradable stent coating J. Biomed. Mater. Res. A 80 2007 732 741 (Pubitemid 46239086)
81. K. Park Dual drug-eluting stent J. Control. Release 159 2012 1
82. V.V. Ranade, and J.B. Cannon Drug Delivery Systems 2011 CRC Press
83. M.S. Kim, J.H. Kim, B.H. Min, K. Park, and H.B. Lee Implantable delivery systems Drugs Pharm. Sci. 194 2010 293 308
84. C.P. McCoy, L. Donnelly, C.R. Edwards, J.L. Gray, and C. Rooney Triggered release of therapeutics from medical polymers Gummi Fasern Kunststoffe 60 2007 158 163 (Pubitemid 46883359)
85. D.A. LaVan, T. McGuire, and R. Langer Small-scale systems for in vivo drug delivery Nat. Biotechnol. 21 2003 1184 1191 (Pubitemid 37186175)
86. F.J. Martin, and C. Grove Microfabricated drug delivery systems: concepts to improve clinical benefit Biomed. Microdevices 3 2001 97 107 (Pubitemid 32707571)
87. P. Telleman Micro technology: the future for life sciences Probe Microsc. 2 2001 203 211 (Pubitemid 34193666)
88. M.D. Phale, and D. Korgaonkar MEMS: a new drug delivery system J. Pharm. Res. 2 2009 1394 1396
89. J.J. Wykrzykowska, Y. Onuma, and P.W. Serruys Advances in stent drug delivery: the future is in bioabsorbable stents Expert Opin. Drug Deliv. 6 2009 113 126